The next Innovation Network Open Meeting will be on 4th March between 10:00-12.30
Scheduled for a day after the UK Budget there will be updates on business growth and innovation opportunities.
Session will provide.
a) Update from national Industry and Government leaders on recovery and future plans
b) Clinical Leads for Innovation will share 2021/22 priorities for NHS and Social Care
c) Investment partners will discuss how to improve access to support, funds and infrastructure to best capture domestic and international opportunities
d) Hear from Scotland’s Clinicians, Academics and Industrialists on progress with the Cancer Diagnostics Moon Shot- 25 by 25- radical innovation in skin care
Registration here- https://book.shsc.scot/innovationnetwork
Draft Agenda
|
10.00 |
Meeting Chair |
Prof David Crossman Chief Scientist Officer Scottish Government |
|
10.05 |
Life Science Industry, Health and Social Care Update- Conversation |
Mary McAllan Director of Economic Development Scottish Government Tom Steele Chair NHS SAS and Co-Chair Innovation Steering Group Christine McLaughlin Director of Planning Scottish Government and Co-Chair Innovation Steering Group Dave Tudor Managing Director, Medicines Manufacturing Innovation Centre and Co-Chair Life Science Industry Leadership Group Mary Jones (Deputy Director, Strategy, Investment, and Manufacturing) Office of Life Science UK Government Richard Hebdon Life Sciences Lead Innovate UK
Chair Euan Dick Head of CSO |
|
10.35 |
NHS and Social Care - Priorities for Innovation in Scotland Exploring Partnership Opportunities-Conservation
|
Prof Graeme Houston, Dr David Low, Dr Neil Patel and Prof Tim Welsh- Scotland’s Leads for Innovation in Health and Social Care
Chair Colin MacBean Depute Director Economy |
|
11.00 |
Investment-Creating the Optimum Investment Ecosystem for Rapid Growth
Shortening the Distance between Innovator and Customer-Conversation
|
Katrine Feldinger Capital Investment Scottish Government Alan Petters and James Norman Dell Bank International Richard Higginson Par Equity Investment Network Duncan Moore Chair Scottish Life Science Association Grahame Watson Scottish Health Innovation Ltd James Blackwood iCaird A. Sinclair Dunlop Managing Partner Venture Capital Epidarex (pre-recorded) NVidia-Investment Partners Gordon Beattie Director of National Procurement NHS
Chair Ian Campbell Life Arc |
|
12.00 |
Diagnosing Cancer within 25 Days by 2025-moon-shot exploration National Industry, NHS, Social Care and academia collaboration |
Scotland’s Dermatology Consortium - Clinical and Industrial Leaders
Chair Prof David Harrison |
|
12.30 |
Concluding Remarks |
Prof David Crossman Chief Scientist Officer
|
Last Updated On: 11 February 2021